Goldman Sachs’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $113M | Buy |
2,621,251
+397,943
| +18% | +$17.2M | 0.02% | 700 |
|
|
2025
Q1 | $76.9M | Buy |
2,223,308
+188,119
| +9% | +$6.5M | 0.01% | 807 |
|
|
2024
Q4 | $55.8M | Sell |
2,035,189
-16,784
| -0.8% | -$461K | 0.01% | 1006 |
|
|
2024
Q3 | $52.2M | Sell |
2,051,973
-246,066
| -11% | -$6.26M | 0.01% | 1031 |
|
|
2024
Q2 | $58.2M | Buy |
2,298,039
+672,280
| +41% | +$17M | 0.01% | 914 |
|
|
2024
Q1 | $50.3M | Sell |
1,625,759
-1,640,876
| -50% | -$50.7M | 0.01% | 993 |
|
|
2023
Q4 | $132M | Buy |
3,266,635
+1,841,478
| +129% | +$74.3M | 0.02% | 547 |
|
|
2023
Q3 | $37.6M | Buy |
1,425,157
+399,689
| +39% | +$10.5M | 0.01% | 1095 |
|
|
2023
Q2 | $17.6M | Buy |
1,025,468
+50,237
| +5% | +$864K | ﹤0.01% | 1646 |
|
|
2023
Q1 | $16.2M | Sell |
975,231
-380,065
| -28% | -$6.3M | ﹤0.01% | 1671 |
|
|
2022
Q4 | $10.3M | Buy |
1,355,296
+145,086
| +12% | +$1.11M | ﹤0.01% | 2108 |
|
|
2022
Q3 | $12M | Buy |
1,210,210
+254,698
| +27% | +$2.53M | ﹤0.01% | 1986 |
|
|
2022
Q2 | $8.68M | Buy |
955,512
+232,765
| +32% | +$2.11M | ﹤0.01% | 2249 |
|
|
2022
Q1 | $7.34M | Buy |
722,747
+9,839
| +1% | +$99.9K | ﹤0.01% | 2494 |
|
|
2021
Q4 | $11.9M | Buy |
712,908
+94,369
| +15% | +$1.57M | ﹤0.01% | 2140 |
|
|
2021
Q3 | $29M | Buy |
618,539
+186,906
| +43% | +$8.76M | 0.01% | 1456 |
|
|
2021
Q2 | $26.3M | Sell |
431,633
-174,935
| -29% | -$10.7M | 0.01% | 1533 |
|
|
2021
Q1 | $37.4M | Sell |
606,568
-19,917
| -3% | -$1.23M | 0.01% | 1224 |
|
|
2020
Q4 | $44.5M | Buy |
626,485
+57,158
| +10% | +$4.06M | 0.01% | 1028 |
|
|
2020
Q3 | $21.4M | Buy |
569,327
+195,858
| +52% | +$7.35M | 0.01% | 1435 |
|
|
2020
Q2 | $12.2M | Sell |
373,469
-54,090
| -13% | -$1.76M | ﹤0.01% | 1828 |
|
|
2020
Q1 | $12.4M | Buy |
427,559
+201,500
| +89% | +$5.84M | ﹤0.01% | 1657 |
|
|
2019
Q4 | $7.92M | Buy |
226,059
+55,177
| +32% | +$1.93M | ﹤0.01% | 2163 |
|
|
2019
Q3 | $3.67M | Buy |
170,882
+32,544
| +24% | +$699K | ﹤0.01% | 2506 |
|
|
2019
Q2 | $3.73M | Buy |
+138,338
| New | +$3.73M | ﹤0.01% | 2461 |
|